Indications for use of porous hydroxyapatite at time of endosteal implant placement.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Placement of coralline porous hydroxyapatite (PHA) at the time of first stage endosteal implant surgery has been shown to be effective in preventing mucosal dehiscence when the buccal cortex is perforated during implant placement. PHA was used to obliterate the space around the occlusal end of endosteal implants placed during tooth extraction. When vital structures would be jeopardized by full implant insertion, PHA can be placed in the area around the protruding implant to prevent mucoperiosteal flap fenestration.

Original languageEnglish (US)
JournalCompendium (Newtown, Pa.)
Volume10
Issue number6
StatePublished - Jun 1989
Externally publishedYes

Fingerprint

Durapatite
Tooth Extraction
Cheek
coralline hydroxyapatite

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Indications for use of porous hydroxyapatite at time of endosteal implant placement. / Kraut, Richard A.

In: Compendium (Newtown, Pa.), Vol. 10, No. 6, 06.1989.

Research output: Contribution to journalArticle

@article{5e4f72d7ea084b7bb1ddee206a46d414,
title = "Indications for use of porous hydroxyapatite at time of endosteal implant placement.",
abstract = "Placement of coralline porous hydroxyapatite (PHA) at the time of first stage endosteal implant surgery has been shown to be effective in preventing mucosal dehiscence when the buccal cortex is perforated during implant placement. PHA was used to obliterate the space around the occlusal end of endosteal implants placed during tooth extraction. When vital structures would be jeopardized by full implant insertion, PHA can be placed in the area around the protruding implant to prevent mucoperiosteal flap fenestration.",
author = "Kraut, {Richard A.}",
year = "1989",
month = "6",
language = "English (US)",
volume = "10",
journal = "The Compendium of continuing education in dentistry",
issn = "1548-8578",
publisher = "Dental Learning Systems Co., Inc.",
number = "6",

}

TY - JOUR

T1 - Indications for use of porous hydroxyapatite at time of endosteal implant placement.

AU - Kraut, Richard A.

PY - 1989/6

Y1 - 1989/6

N2 - Placement of coralline porous hydroxyapatite (PHA) at the time of first stage endosteal implant surgery has been shown to be effective in preventing mucosal dehiscence when the buccal cortex is perforated during implant placement. PHA was used to obliterate the space around the occlusal end of endosteal implants placed during tooth extraction. When vital structures would be jeopardized by full implant insertion, PHA can be placed in the area around the protruding implant to prevent mucoperiosteal flap fenestration.

AB - Placement of coralline porous hydroxyapatite (PHA) at the time of first stage endosteal implant surgery has been shown to be effective in preventing mucosal dehiscence when the buccal cortex is perforated during implant placement. PHA was used to obliterate the space around the occlusal end of endosteal implants placed during tooth extraction. When vital structures would be jeopardized by full implant insertion, PHA can be placed in the area around the protruding implant to prevent mucoperiosteal flap fenestration.

UR - http://www.scopus.com/inward/record.url?scp=0024673958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024673958&partnerID=8YFLogxK

M3 - Article

C2 - 2557977

AN - SCOPUS:0024673958

VL - 10

JO - The Compendium of continuing education in dentistry

JF - The Compendium of continuing education in dentistry

SN - 1548-8578

IS - 6

ER -